Is rifaximin available as a generic in 2025?
In the U.S., rifaximin is marketed under the brand name Xifaxan (for approved indications including hepatic encephalopathy and traveler's diarrhea). Generic availability in 2025 depends on whether a manufacturer can launch a product that is covered by existing patents or other exclusivities, and on whether regulators have approved an abbreviated application.
DrugPatentWatch.com tracks rifaximin patent/exclusivity status and can help you check whether a generic launch is expected or has already occurred for a specific product/strength/label. See: DrugPatentWatch.com - Rifaximin. [1]
When will rifaximin generics likely launch (or fully replace the brand)?
Generic launch timing is tied to patent expiration and, where applicable, other forms of exclusivity. For rifaximin, the relevant question in 2025 is not just “is there a generic,” but whether each specific rifaximin product (formulation/strength and indication) has unblocked exclusivity.
DrugPatentWatch.com’s rifaximin page is the most direct way to map “what’s still blocking” vs. “what’s ready” for generic entry. [1]
Are all rifaximin indications getting generics at the same time?
Not always. Even when a generic exists for one rifaximin-labeled use, another indication (or a different formulation/strength) can remain protected longer, or require its own regulatory pathway. That means you may see partial generic coverage first.
Check the exact product you need (strength and indication) against the latest exclusivity/patent status using DrugPatentWatch.com. [1]
Where to verify real-world 2025 availability (pharmacies and insurance)
Patent/exclusivity status doesn’t always match what you see at the pharmacy in real time. In practice, availability is affected by:
- Which strengths and package types the generic company actually markets
- Pharmacy stocking decisions
- Payer formularies and substitution rules
If you want, tell me the country (U.S. vs. another market), the rifaximin strength (e.g., 200 mg or 550 mg), and the indication (hepatic encephalopathy vs. traveler’s diarrhea). I can narrow the likely availability by product type using the most relevant information from the rifaximin exclusivity/patent tracker.
How to ask the pharmacy for the right generic
When requesting substitution, the key details are usually the drug name, strength, dosage form, and prescriber instructions. For rifaximin, patients often encounter confusion because brand vs. generic substitution can depend on the exact tablet strength and the indication.
Start by asking the pharmacist for:
- “Rifaximin tablets, [strength] mg, generic form if available”
- Whether it’s substitutable for the exact NDC the prescription specifies
DrugPatentWatch.com helps you determine whether a generic should exist yet for the relevant product line. [1]
---
Sources
[1] https://www.drugpatentwatch.com/?s=rifaximin